ATAI Life Sciences
ATAI
ATAI
89 hedge funds and large institutions have $16.1M invested in ATAI Life Sciences in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 15
0.28% less ownership
Funds ownership: 7.5% → 7.22% (-0.28%)
34% less capital invested
Capital invested by funds: $24.6M → $16.1M (-$8.43M)
Holders
89
Holding in Top 10
1
Calls
$200K
Puts
$180K
Top Buyers
| 1 | +$3.54M | |
| 2 | +$420K | |
| 3 | +$67.7K | |
| 4 |
SG Americas Securities
New York
|
+$65K |
| 5 |
VF
Virtu Financial
New York
|
+$62K |
Top Sellers
| 1 | -$2.09M | |
| 2 | -$1.56M | |
| 3 | -$513K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$405K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$364K |